iSpecimen Inc. (ISPC) Tops Q2 EPS by 9c

iSpecimen Inc. (NASDAQ: ISPC) reported Q2 EPS of ($0.19), $0.09 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $2.86 million versus the consensus estimate of $2.88 million.

For earnings history and earnings-related data on iSpecimen Inc. (ISPC) click here.

You May Also Be Interested In

• Google execs convened 'all-hands' meeting last week to address AI unit reorganizations amid staff concerns - Reuters
• Citi raises Huya price target to $4.60 from $4.40
• Goldman Sachs expects July core PCE to rise 0.23%